The 2026 IPO streak continues as Electra Therapeutics has filed to go public to support its immunology and cancer pipeline.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
The 2026 IPO streak continues as Electra Therapeutics has filed to go public to support its immunology and cancer pipeline.